Kamada (KMDA) Enterprise Value (2012 - 2026)
Kamada (KMDA) posted quarterly Enterprise Value of -$73.1 million for Q1 2026, up 4.07% year-on-year from -$70.3 million in Q1 2025, and up 3.33% on a QoQ basis from -$75.7 million in Q4 2025.
Kamada (KMDA) Enterprise Value (2012 - 2026) Analysis & Trends
Kamada (KMDA) has reported Enterprise Value for 15 consecutive years, with -$73.1 million the latest figure, recorded in Q1 2026.
- Quarterly Enterprise Value rose 4.07% year-over-year to -$73.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$73.1 million (up 4.07% YoY) and the FY2025 annual result came in at -$75.7 million, up 3.59% from the prior year.
- Enterprise Value improved to -$73.1 million in Q1 2026 per KMDA's latest filing, from -$75.7 million in the prior quarter.
- Over the last five years, Enterprise Value for KMDA reached as high as -$29933.0 in Q2 2022 and fell as low as -$31.3 billion in Q3 2022.
- A 5-year average of -$1.9 billion and a median of -$56.5 million in 2024 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2022 — Enterprise Value jumped 99.97% — and 2023, when it sank 72689.23%.
- Year by year, Enterprise Value stood at -$34.3 million in 2022, then tumbled by 62.83% to -$55.8 million in 2023, then plunged by 40.68% to -$78.5 million in 2024, then gained by 3.59% to -$75.7 million in 2025, then increased by 3.33% to -$73.1 million in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered -$73.1 million, -$75.7 million, and -$72.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | -1.86 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -3.74 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -1.94 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -4.05 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -2.15 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -33.59 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -1.80 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -1.32 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -428.00 Mn |
| 10 | Kamada | 401.22 Mn | 328.07 Mn | 19.12 Mn | -73.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -73.15 Mn |
| Dec 31, 2025 | -75.67 Mn |
| Sep 30, 2025 | -72.00 Mn |
| Jun 30, 2025 | -65.99 Mn |
| Mar 31, 2025 | -76.25 Mn |
| Dec 31, 2024 | -78.48 Mn |
| Sep 30, 2024 | -72.00 Mn |
| Jun 30, 2024 | -56.55 Mn |
| Mar 31, 2024 | -48.19 Mn |
| Dec 31, 2023 | -55.79 Mn |
| Sep 30, 2023 | -52.60 Mn |
| Jun 30, 2023 | -21.79 Mn |
| Mar 31, 2023 | -27.12 Mn |
| Dec 31, 2022 | -34.26 Mn |
| Sep 30, 2022 | -31.25 Bn |
| Jun 30, 2022 | -29,933.00 |
| Mar 31, 2022 | -21.97 Mn |
| Dec 31, 2021 | -145.29 Mn |
| Sep 30, 2021 | -99.84 Mn |
| Jun 30, 2021 | -104.55 Mn |